These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 10838852)

  • 21. Fluconazole-resistant cryptococcal meningitis.
    Momoff N; Parrish A
    S Afr Med J; 2003 Jun; 93(6):444. PubMed ID: 12916384
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of cryptococcal meningitis.
    Zingman BS
    N Engl J Med; 1997 Nov; 337(21):1557; author reply 1557-8. PubMed ID: 9380128
    [No Abstract]   [Full Text] [Related]  

  • 23. Successful lumbarperitoneal derivation during refractory intracranial pressure due to cryptococcal meningitis, in an HIV-negative patient.
    Lanternier F; Lecuit M; Lortholary O; Roujeau T; Renier D; Bougnoux ME
    Med Mal Infect; 2008 May; 38(5):285-6. PubMed ID: 18455341
    [No Abstract]   [Full Text] [Related]  

  • 24. Granulocyte colony stimulating factor therapy of experimental cryptococcal meningitis.
    Graybill JR; Bocanegra R; Lambros C; Luther MF
    J Med Vet Mycol; 1997; 35(4):243-7. PubMed ID: 9292420
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical microbiological case: fever and headache in a heavy consumer of eucalyptus extract.
    Tascini C; Ferranti S; Gemignani G; Messina F; Menichetti F
    Clin Microbiol Infect; 2002 Jul; 8(7):437, 445-6. PubMed ID: 12199856
    [No Abstract]   [Full Text] [Related]  

  • 26. Effects of fluconazole singly and in combination with 5-fluorocytosine or amphotericin B in the treatment of cryptococcal meningoencephalitis in an intracranial murine model.
    Hossain MA; Mukherjee PK; Reyes G; Long L; Ghannoum MA
    J Chemother; 2002 Aug; 14(4):351-60. PubMed ID: 12420852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Cryptococcal meningitis].
    van Spil WE; Nooijen S; de Jong PY; Aliredjo RP; de Sévaux RG; Verhave JC
    Ned Tijdschr Geneeskd; 2015; 159():A8478. PubMed ID: 25827149
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cryptococcus and HIV.
    Akhtar S; Aggarwal N; Demkowicz R; Andreatos N; Gupta M
    QJM; 2020 May; 113(5):347-348. PubMed ID: 31800060
    [No Abstract]   [Full Text] [Related]  

  • 29. [Neurologic cryptococcosis: meningitis of the immunosuppressed patient].
    Kallel K; Mejri H; Belhadj S; Boussen N; Kilani B; Zouiten F; Ben Abid H; Zribi A; Chaker E
    Tunis Med; 1999 Jan; 77(1):45-9. PubMed ID: 10333698
    [No Abstract]   [Full Text] [Related]  

  • 30. A systematic review of fluconazole resistance in clinical isolates of Cryptococcus species.
    Bongomin F; Oladele RO; Gago S; Moore CB; Richardson MD
    Mycoses; 2018 May; 61(5):290-297. PubMed ID: 29377368
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular identification, antifungal resistance and virulence of Cryptococcus neoformans and Cryptococcus deneoformans isolated in Seville, Spain.
    Gago S; Serrano C; Alastruey-Izquierdo A; Cuesta I; Martín-Mazuelos E; Aller AI; Gómez-López A; Mellado E
    Mycoses; 2017 Jan; 60(1):40-50. PubMed ID: 27633849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifungal susceptibilities of Cryptococcus neoformans cerebrospinal fluid isolates and clinical outcomes of cryptococcal meningitis in HIV-infected patients with/without fluconazole prophylaxis.
    Manosuthi W; Sungkanuparph S; Thongyen S; Chumpathat N; Eampokalap B; Thawornwan U; Foongladda S
    J Med Assoc Thai; 2006 Jun; 89(6):795-802. PubMed ID: 16850679
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Cryptococcal meningitis in children: description of 3 cases].
    Ndiaye M; Diagne NR; Seck LB; Sow AD; Sène MS; Diop AG; Sow HD; Ndiaye MM
    Med Trop (Mars); 2011 Apr; 71(2):176-8. PubMed ID: 21695878
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correspondence of in vitro and in vivo fluconazole dose-response curves for Cryptococcus neoformans.
    Larsen RA; Bauer M; Thomas AM; Sanchez A; Citron D; Rathbun M; Harrison TS
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3297-301. PubMed ID: 16048939
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amino acid substitution in Cryptococcus neoformans lanosterol 14-α-demethylase involved in fluconazole resistance in clinical isolates.
    Bosco-Borgeat ME; Mazza M; Taverna CG; Córdoba S; Murisengo OA; Vivot W; Davel G
    Rev Argent Microbiol; 2016; 48(2):137-42. PubMed ID: 27311753
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cryptococcal meningitis and sarcoidosis.
    Ross JJ; Katz JD
    Scand J Infect Dis; 2002; 34(12):937-9. PubMed ID: 12587633
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cryptococcus neoformans meningitis in patients with AIDS at the Saint Thomas Hospital].
    Sierra LO; Suárez M; Rodríguez French A
    Rev Med Panama; 1996; 21(1-2):46-50. PubMed ID: 8966238
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Burden of cryptococcal meningitis in Malawi.
    Makombe SD; Nkhata A; Schouten EJ; Kamoto K; Harries AD
    Trop Doct; 2009 Jan; 39(1):32-4. PubMed ID: 19211421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.
    Smith KD; Achan B; Hullsiek KH; McDonald TR; Okagaki LH; Alhadab AA; Akampurira A; Rhein JR; Meya DB; Boulware DR; Nielsen K;
    Antimicrob Agents Chemother; 2015 Dec; 59(12):7197-204. PubMed ID: 26324276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification of patients with acute AIDS-associated cryptococcal meningitis who can be effectively treated with fluconazole: the role of antifungal susceptibility testing.
    Witt MD; Lewis RJ; Larsen RA; Milefchik EN; Leal MA; Haubrich RH; Richie JA; Edwards JE; Ghannoum MA
    Clin Infect Dis; 1996 Feb; 22(2):322-8. PubMed ID: 8838190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.